BD Launches Halo One Thin-Walled Guiding Sheath
June 5, 2020—BD (Becton, Dickinson and Company) announced the launch of the Halo One thin-walled guiding sheath, which is designed to perform as both a guiding sheath and an introducer sheath for use in peripheral artery and venous procedures requiring percutaneous introduction of intravascular devices.
Enrollment Begins in ACTIVATE I Study of Alucent NVS Vessel Restoration System
May 27, 2020—Alucent Biomedical Inc. announced that it has enrolled the first two patients in ACTIVATE I, a phase 1 clinical trial to evaluate the safety and efficacy of its Natural Vascular Scaffolding (NVS) technology for the treatment of peripheral artery disease (PAD) of the lower extremities.
Continuing Coverage: Paclitaxel In PAD
VIVA's Paclitaxel Analysis Finds Increased Mortality Risk, But No Dose Association; Lead Author Encourages Close Read
May 27, 2020—Earlier this month, VIVA Physicians announced the publication of an analysis of mortality and paclitaxel-coated devices by Krishna Rocha-Singh, MD, et al, which is available online ahead of print in Circulation.
Twelve-Month Data Published From European TOBA III Study of Intact Vascular's Tack Endovascular System
May 13, 2020—Intact Vascular, Inc. announced that the 12-month results from the Tack Optimized Balloon Angioplasty (TOBA) III clinical trial were published by Marianne Brodmann, MD, et al in the Journal of Vascular Surgery.
Getinge Introduces Larger-Diameter Advanta V12 Balloon-Expandable Covered Stent to Treat Iliac Artery Disease
May 6, 2020—Getinge announced the commercial introduction of a larger-diameter Advanta V12 balloon-expandable covered stent, which expands from 12 to 16 mm, to treat iliac arterial occlusive disease.
FDA Approves Intact Vascular's Tack Endovascular System for BTK Dissection Repair
April 14, 2020—Intact Vascular, Inc. announced FDA approval of its Tack (4-F) endovascular system for repair of postangioplasty dissections in the mid/distal popliteal, tibial, and/or peroneal below-the-knee (BTK) arteries ranging in diameter from 1.5 to 4.5 mm.
One-Year Outcomes Reported for PQ Bypass' Detour System to Treat Femoropopliteal Lesions
April 7, 2020—The 1-year safety and effectiveness results from the DETOUR I trial of the Detour system (PQ Bypass, Inc.) for percutaneous femoropopliteal bypass were published by Dainis K. Krievins, MD, et al online in Journal of Vascular Surgery (JVS). The Detour system percutaneously deploys modular stent grafts to bypass femoropopliteal lesions through a transvenous route.
SIR Issues Clinical Notification on Aerosol-Generating Procedures
March 27, 2020—The Society of Interventional Radiology (SIR) has issued a clinical notification to provide medical decision-making guidance on how to perform aerosol-generating procedures (AGP) safely in the interventional radiology suite.
American College of Surgeons Releases Clinical Guidance for Elective Surgical Case Triage During COVID-19 Outbreak
March 25, 2020—The American College of Surgeons (ACS) announced continued guidance for surgeons to curtail recommendations for elective surgical procedures to preserve the necessary resources for care of critically ill patients during the COVID-19 pandemic.
Vascular Society of Great Britain and Ireland Provides Guidelines for Managing Treatment Amid COVID-19 Pandemic
March 20, 2020—Professor Chris Imray, MD, President of the Vascular Society of Great Britain and Ireland, announced guidelines from the society to address the rapidly evolving situation regarding the COVID-19 virus as it impacts patients and the particular challenges for health care workers.
Continuing Coverage: Paclitaxel In PAD
No Mortality Difference Observed in JEVT Meta-Analysis of CLTI Patients Treated With Paclitaxel
February 21, 2020—Investigators seeking to explore the risks of paclitaxel-coated devices (PCDs) in patients with chronic limb-threatening ischemia (CLTI) have published a new meta-analysis finding no difference in short- to midterm mortality versus outcomes in patients treated with uncoated devices.
Study Reports Impact of Diabetes on 5-Year Outcomes After Endovascular Therapy for PAD
February 12, 2020—Findings from a study evaluating the long-term impact of diabetes mellitus in patients with peripheral artery disease (PAD) who underwent endovascular therapy were published by Michael S. Lee, MD, et al in Vascular Medicine (2020;25:33–40).
Real-World Data Presented for VentureMed’s Flex Vessel Prep System to Treat Long CTOs
January 30, 2020—VentureMed Group, Inc. announced that data for the company’s Flex vessel preparation (VP) system were presented at ISET 2020, the International Symposium on Endovascular Therapy held January 22–25 in Hollywood, Florida.
Interim Long-Term Safety Data Presented for BD’s Lutonix 014 DCB in BTK Arteries
January 29, 2020—BD (Becton, Dickinson and Company) announced the presentation of interim findings from the Lutonix BTK investigational device exemption trial of the company’s Lutonix 014 drug-coated balloon (DCB) versus standard balloon angioplasty for treatment of below-the-knee (BTK) arteries.
Sponsored by Medtronic
Lower Extremity Revascularization: Recent Past and Future Directions
Commentary on five key articles related to peripheral artery disease published over the past year, top headlines, and critical questions to be answered for the future.
By Joseph J. Ingrassia, MD; Matthew T. Finn, MD; and Sahil A. Parikh, MD
Sponsored by Boston Scientific Corporation
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in Europe.